Koene Bart M, Soliman Hamad Mohamed A, Bouma Wobbe, Mariani Massimo A, Peels Kathinka C, van Dantzig Jan-Melle, van Straten Albert H
Department of Cardiothoracic Surgery, Catharina Hospital, Michelangelolaan 2, Postbus 1350, 5602 ZA, Eindhoven, The Netherlands,
Clin Res Cardiol. 2014 Feb;103(2):133-40. doi: 10.1007/s00392-013-0629-3. Epub 2013 Oct 18.
In this study, we sought to determine the effect of the mean transprosthetic pressure gradient (TPG), measured at 6 weeks after aortic valve replacement (AVR) or AVR with coronary artery bypass grafting (CABG) on late all-cause mortality.
Between January 1998 and March 2012, 2,276 patients (mean age 68 ± 11 years) underwent TPG analysis at 6 weeks after AVR (n = 1,318) or AVR with CABG (n = 958) at a single institution. Mean TPG was 11.6 ± 7.8 mmHg and median TPG 11 mmHg. Based on the TPG, the patients were split into three groups: patients with a low TPG (<10 mmHg), patients with a medium TPG (10-19 mmHg) and patients with a high TPG (≥ 20 mmHg). Cox proportional-hazard regression analysis was used to determine univariate predictors and multivariate independent predictors of late mortality.
Overall survival for the entire group at 1, 3, 5, and 10 years was 97, 93, 87 and 67%, respectively. There was no significant difference in long-term survival between patients with a low, medium or high TPG (p = 0.258). Independent predictors of late mortality included age, diabetes, peripheral vascular disease, renal dysfunction, chronic obstructive pulmonary disease, a history of a cerebrovascular accident and cardiopulmonary bypass time. Prosthesis-patient mismatch (PPM), severe PPM and TPG measured at 6 weeks postoperatively were not significantly associated with late mortality.
TPG measured at 6 weeks after AVR or AVR with CABG is not an independent predictor of all-cause late mortality and there is no significant difference in long-term survival between patients with a low, medium or high TPG.
在本研究中,我们试图确定主动脉瓣置换术(AVR)或联合冠状动脉旁路移植术(CABG)的AVR术后6周测得的平均跨瓣压差(TPG)对晚期全因死亡率的影响。
1998年1月至2012年3月期间,2276例患者(平均年龄68±11岁)在单一机构接受了AVR(n = 1318)或联合CABG的AVR(n = 958)术后6周的TPG分析。平均TPG为11.6±7.8 mmHg,中位数TPG为11 mmHg。根据TPG,患者被分为三组:低TPG组(<10 mmHg)、中TPG组(10 - 19 mmHg)和高TPG组(≥20 mmHg)。采用Cox比例风险回归分析来确定晚期死亡率的单因素预测指标和多因素独立预测指标。
整个组在1年、3年、5年和10年的总生存率分别为97%、93%、87%和67%。低、中、高TPG组患者的长期生存率无显著差异(p = 0.258)。晚期死亡率的独立预测指标包括年龄、糖尿病、外周血管疾病、肾功能不全、慢性阻塞性肺疾病、脑血管意外病史和体外循环时间。术后6周测得的人工瓣膜-患者不匹配(PPM)、严重PPM和TPG与晚期死亡率无显著相关性。
AVR或联合CABG的AVR术后6周测得的TPG不是全因晚期死亡率的独立预测指标,低、中、高TPG组患者的长期生存率无显著差异。